Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Surgeons detail challenges in treating 'tranq' wounds amid Philadelphia's Xylazine crisis
A new study examining the treatment of xylazine-associated wounds in Philadelphia sheds light on the severe medical ...